St. Jude Children’s Research Hospital Comprehensive Cancer Center is the first and only NCI-designated comprehensive cancer center devoted solely to children. The center has received the highest ranking of “exceptional” in its two most recent NCI reviews. In 2022, NCI extended its grant funding period based on sustained progress, stability and longevity. The center is organized as five cross-disciplinary, multidepartmental programs aligned to specific diseases and research concepts: developmental biology and solid tumor; neurobiology and brain tumor; hematological malignancies; cancer control and survivorship; and cancer biology. The center also supports 10 core resource laboratories to facilitate research design, implementation, analysis, interpretation and reporting. The center is a member of the Pediatric Cancer Dependencies Accelerator. Through the center, St. Jude aims to improve outcomes and understanding of pediatric cancer to benefit patients and survivors in its catchment area, and to extend these findings to the nation and the world.
